Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies

被引:76
作者
Neves, M [1 ]
Gano, L
Pereira, N
Costa, MC
Costa, MR
Chandia, M
Rosado, M
Fausto, R
机构
[1] Inst Tecnol & Nucl, Sacavem, Portugal
[2] Inst Nacl Engn & Tecnol Ind, Lisbon, Portugal
[3] Chilean Nucl Energy Comiss, Santiago, Chile
[4] Univ Coimbra, Dept Chem CQC, Coimbra, Portugal
关键词
bisphosphonates; hydroxyapatite bindings; molecular modeling; therapeutic radiopharmaceuticals;
D O I
10.1016/S0969-8051(01)00305-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Bisphosphonates (BPs) are characterized by a P-C-P backbone structure and two phosphonic acid groups bonded to the same carbon, and are established as osteoclast-mediated bone resorption inhibitors. The nature of the groups attached to the central carbon atom are responsible in determining the potency of bisphosphonates as anti-resorption drugs. However, it is not yet clear the exact relationship between their molecular structure and pharmacologic activities. In this study, molecular geometries of pamidronate, alendronate and neridronate, differing only in the length of the aliphatic chains, were predicted by molecular mechanics and their interactions with hydroxyapatite, the main bone mineral component, were examined. We report the synthesis and radiochemical characterization of Sm-153 complexes with pamidronate, alendronate and neridronate. Hydroxyapatite binding and biodistribution studies of these complexes have shown a good correlation With the theoretical molecular modeling interaction studies. So, it is possible to conclude that computational chemistry techniques are a good approach to evaluate specific interaction,, and may play a relevant role in determining the relative ability of BPs to mineral bone, and open new perspectives to the design of new BPs with increased pharmacological activity. These techniques could be extended to BPs as ligands to carrier radioactive metals, aiming for new bone therapeutic radiopharmaceuticals. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 33 条
[1]   STRUCTURE OF DISODIUM DIHYDROGEN 1-HYDROXYETHYLIDENEDIPHOSPHONATE TETRAHYDRATE - BONE-GROWTH REGULATOR [J].
BARNETT, BL ;
STRICKLAND, LC .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (MAY) :1212-1214
[2]   INTERACTIONS AT THE ORGANIC INORGANIC INTERFACE - BINDING MOTIFS FOR PHOSPHONATES AT THE SURFACE OF BARITE CRYSTALS [J].
BLACK, SN ;
BROMLEY, LA ;
COTTIER, D ;
DAVEY, RJ ;
DOBBS, B ;
ROUT, JE .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS, 1991, 87 (20) :3409-3414
[3]  
Boissier S, 2000, CANCER RES, V60, P2949
[4]  
Burket U., 1982, ACS MONOGRAPH, V177
[5]   Molecular modelling of the mechanism of action of phosphonate retarders on hydrating cements [J].
Coveney, PV ;
Humphries, W .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS, 1996, 92 (05) :831-841
[6]   TECHNETIUM CHEMISTRY AND TECHNETIUM RADIOPHARMACEUTICALS [J].
DEUTSCH, E ;
LIBSON, K ;
JURISSON, S ;
LINDOY, LF .
PROGRESS IN INORGANIC CHEMISTRY, 1983, 30 :75-139
[7]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100
[8]   DIPHOSPHONATES INHIBIT FORMATION OF CALCIUM PHOSPHATE CRYSTALS IN VITRO AND PATHOLOGICAL CALCIFICATION IN VIVO [J].
FRANCIS, MD ;
RUSSELL, RGG ;
FLEISCH, H .
SCIENCE, 1969, 165 (3899) :1264-&
[9]  
FRANCIS MD, 1980, J NUCL MED, V21, P1189
[10]   Bisphosphonates induce breast cancer cell death in vitro [J].
Fromigue, O ;
Lagneaux, L ;
Body, JJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (11) :2211-2221